204 related articles for article (PubMed ID: 32980620)
1. Intensity of anticoagulation and survival in patients hospitalized with COVID-19 pneumonia.
Hsu A; Liu Y; Zayac AS; Olszewski AJ; Reagan JL
Thromb Res; 2020 Dec; 196():375-378. PubMed ID: 32980620
[TBL] [Abstract][Full Text] [Related]
2. Anticoagulation and bleeding risk in patients with COVID-19.
Musoke N; Lo KB; Albano J; Peterson E; Bhargav R; Gul F; DeJoy R; Salacup G; Pelayo J; Tipparaju P; Azmaiparashvili Z; Patarroyo-Aponte G; Rangaswami J
Thromb Res; 2020 Dec; 196():227-230. PubMed ID: 32916565
[TBL] [Abstract][Full Text] [Related]
3. The Association of Anticoagulation Intensity with Outcomes in Hospitalized COVID-19 Patients.
Zheng R; Solomon A; DiLorenzo M; Rajendran I; Park J; Dhongade V; Garcia MA; Eberhardt RT; Sloan JM; Weinberg J; Klings ES
Adv Hematol; 2024; 2024():8838308. PubMed ID: 38500844
[TBL] [Abstract][Full Text] [Related]
4. National Trends in Anticoagulation Therapy for COVID-19 Hospitalized Adults in the United States: Analyses of the National COVID Cohort Collaborative.
Lee E; Bates B; Kuhrt N; Andersen KM; Visaria A; Patel R; Setoguchi S;
J Infect Dis; 2023 Oct; 228(7):895-906. PubMed ID: 37265224
[TBL] [Abstract][Full Text] [Related]
5. Mortality, critical illness, and mechanical ventilation among hospitalized patients with COVID-19 on therapeutic anticoagulants.
Patel NG; Bhasin A; Feinglass JM; Angarone MP; Cohen ER; Barsuk JH
Thromb Update; 2021; 2():100027. PubMed ID: 38620459
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the Benefits and Risks of Therapeutic Anticoagulation in Patients Admitted with Severe COVID-19 (CRITAC).
Jinn A; Kammermayer M; Mabasa VH; Liu T; Paul TS; Phan N
Can J Hosp Pharm; 2024; 77(2):e3505. PubMed ID: 38601129
[TBL] [Abstract][Full Text] [Related]
7. Thrombotic Events in COVID-19 Are Associated With a Lower Use of Prophylactic Anticoagulation Before Hospitalization and Followed by Decreases in Platelet Reactivity.
Clark CC; Jukema BN; Barendrecht AD; Spanjaard JS; Jorritsma NKN; Smits S; de Maat S; Seinen CW; Verhoef S; Parr NMJ; Sebastian SAE; Koekman AC; van Wesel ACW; van Goor HMR; Spijkerman R; Bongers SH; van der Vries E; Nierkens S; Boes M; Koenderman L; Kaasjager KAH; Maas C
Front Med (Lausanne); 2021; 8():650129. PubMed ID: 33968958
[No Abstract] [Full Text] [Related]
8. Prophylactic Anticoagulation and Thrombosis in Hospitalized Patients with Clinically Stable COVID-19 at Admission: From the Practice-Based Observational Study.
Yamashita Y; Yachi S; Takeyama M; Nishimoto Y; Tsujino I; Nakamura J; Yamamoto N; Nakata H; Ikeda S; Umetsu M; Aikawa S; Hayashi H; Satokawa H; Okuno Y; Iwata E; Ogihara Y; Ikeda N; Kondo A; Iwai T; Yamada N; Ogawa T; Kobayashi T; Mo M;
Ann Vasc Dis; 2024 Mar; 17(1):1-8. PubMed ID: 38628927
[No Abstract] [Full Text] [Related]
9. Post-anticoagulant D-dimer is a highly prognostic biomarker of COVID-19 mortality.
Song X; Ji J; Reva B; Joshi H; Calinawan AP; Mazumdar M; Wisnivesky JP; Taioli E; Wang P; Veluswamy RR
ERJ Open Res; 2021 Jul; 7(3):. PubMed ID: 34230883
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic-Dose Anticoagulation in Hospitalized Patients With COVID-19: Are We Getting Closer to the Truth?
Berg DD
JACC Adv; 2024 Mar; 3(3):100779. PubMed ID: 38938838
[No Abstract] [Full Text] [Related]
11. COVID-19-related prothrombotic changes increase with lung injury and remain unaffected by anticoagulation therapy.
Assinger A
Res Pract Thromb Haemost; 2021 Jan; 5(1):11-13. PubMed ID: 33537524
[No Abstract] [Full Text] [Related]
12. Anticoagulation, immortality, and observations of COVID-19.
Maley JH; Petri CR; Brenner LN; Chivukula RR; Calhoun TF; Vinarsky V; Hardin CC
Res Pract Thromb Haemost; 2020 Jul; 4(5):674-676. PubMed ID: 32685874
[No Abstract] [Full Text] [Related]
13. Anticoagulation outcomes in hospitalized Covid-19 patients: A systematic review and meta-analysis of case-control and cohort studies.
Kamel AM; Sobhy M; Magdy N; Sabry N; Farid S
Rev Med Virol; 2021 May; 31(3):e2180. PubMed ID: 33022834
[TBL] [Abstract][Full Text] [Related]
14. Association of anticoagulation dose and survival in hospitalized COVID-19 patients: A retrospective propensity score-weighted analysis.
Ionescu F; Jaiyesimi I; Petrescu I; Lawler PR; Castillo E; Munoz-Maldonado Y; Imam Z; Narasimhan M; Abbas AE; Konde A; Nair GB
Eur J Haematol; 2021 Feb; 106(2):165-174. PubMed ID: 33043484
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 associated coagulopathy: Thrombosis, hemorrhage and mortality rates with an escalated-dose thromboprophylaxis strategy.
Daughety MM; Morgan A; Frost E; Kao C; Hwang J; Tobin R; Patel B; Fuller M; Welsby I; Ortel TL
Thromb Res; 2020 Dec; 196():483-485. PubMed ID: 33091700
[TBL] [Abstract][Full Text] [Related]
16. The impact of protocol-based high-intensity pharmacological thromboprophylaxis on thrombotic events in critically ill COVID-19 patients.
Atallah B; Sadik ZG; Salem N; El Nekidy WS; Almahmeed W; Park WM; Cherfan A; Hamed F; Mallat J
Anaesthesia; 2021 Mar; 76(3):327-335. PubMed ID: 33047335
[TBL] [Abstract][Full Text] [Related]
17. Venous Thrombo-Embolism in Hospitalized SARS-CoV-2 Patients Treated with Three Different Anticoagulation Protocols: Prospective Observational Study.
Longhitano Y; Racca F; Zanza C; Muncinelli M; Guagliano A; Peretti E; Minerba AC; Mari M; Boverio R; Salio M; Chichino G; Franceschi F; Piccioni A; Abenavoli L; Salvini M; Artico M
Biology (Basel); 2020 Sep; 9(10):. PubMed ID: 32987902
[TBL] [Abstract][Full Text] [Related]
18. Intermediate versus standard-dose prophylactic anticoagulation and statin therapy versus placebo in critically-ill patients with COVID-19: Rationale and design of the INSPIRATION/INSPIRATION-S studies.
Bikdeli B; Talasaz AH; Rashidi F; Sharif-Kashani B; Farrokhpour M; Bakhshandeh H; Sezavar H; Dabbagh A; Beigmohammadi MT; Payandemehr P; Yadollahzadeh M; Riahi T; Khalili H; Jamalkhani S; Rezaeifar P; Abedini A; Lookzadeh S; Shahmirzaei S; Tahamtan O; Matin S; Amin A; Parhizgar SE; Jimenez D; Gupta A; Madhavan MV; Parikh SA; Monreal M; Hadavand N; Hajighasemi A; Maleki M; Sadeghian S; Mohebbi B; Piazza G; Kirtane AJ; Lip GYH; Krumholz HM; Goldhaber SZ; Sadeghipour P
Thromb Res; 2020 Dec; 196():382-394. PubMed ID: 32992075
[TBL] [Abstract][Full Text] [Related]
19. The Use of Therapeutic-Dose Anticoagulation and Its Effect on Mortality in Patients With COVID-19: A Systematic Review.
Wijaya I; Andhika R; Huang I
Clin Appl Thromb Hemost; 2020; 26():1076029620960797. PubMed ID: 33079569
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
